The research team, led by paediatric nephrologist A. Raaijmakers together with S.J.C. Tapawan and senior author S. Bolisetty of the University of New South Wales, combed through outpatient records from 2012 to 2017. Out of 5,117 infants seen at the clinic, 237 newborns carried a diagnosis of hydronephrosis, a prevalence of 4.6 percent that sits comfortably within the internationally reported range. The investigators applied strict inclusion rules: every severity grade of antenatal hydronephrosis was welcome, but infants lost to follow-up, those without a confirmed prenatal diagnosis, and the small number who required surgery within their first year were set aside. Thirty-eight newborns were excluded on those grounds, leaving a cohort of 199 infants whose natural history could be tracked without the distorting effect of early operative intervention.

The technical yardstick at the centre of the analysis is the anteroposterior diameter, the APD, the front-to-back measurement of the renal pelvis that ultrasound machines capture in milliseconds. Recovery was defined as an APD of 10 millimetres or less, the threshold at which the dilated collecting system is considered resolved rather than merely improved. When the researchers ran the statistics, using Pearson Chi-square and Fisher’s exact tests for categorical comparisons and Spearman correlation coefficients to probe the relationship between recovery and potential confounders, the headline finding leapt out: 186 infants, or 93.5 percent of the cohort, showed spontaneous resolution within the first year of life.

Even more remarkable is the tempo of that resolution. Of the infants who recovered, 94.1 percent did so before they reached two months of age. In other words, the swollen kidney that alarmed the prenatal scan typically deflated within the first weeks of life, often before the family had finished the battery of postnatal imaging appointments. For clinicians, this tempo matters enormously. It suggests that the first two months are the decisive window, and that an infant whose APD remains stubbornly elevated past that point deserves closer scrutiny, while the vast majority can be managed with observation alone.

One demographic pattern confirmed what ultrasound literature has long hinted at: boys dominated the cohort, with 156 males versus 43 females. The male predominance reflects well-known anatomical realities, including the higher incidence of pelvi-ureteric junction obstruction and vesico-ureteral reflux in infant boys. But here the study delivered a counterintuitive twist: sex had no bearing on recovery at all, with a p-value of 0.738 indicating that the correlation was statistically indistinguishable from chance. A baby boy with hydronephrosis was just as likely as a baby girl to see the swelling resolve without any intervention.

The determinants that did matter were comorbidities. Forty infants in the cohort, 20.1 percent, carried a relevant additional condition, and this group told a very different story. Infants with congenital anomalies showed a negative Spearman correlation with spontaneous recovery, r-s of minus 0.273 with a p-value of 0.001, while those who developed infections fared even worse, r-s of minus 0.283 with a p-value of 0.002. The negative signs are the crucial technical detail: they mean that as the presence or severity of these comorbidities increases, the probability of the hydronephrosis resolving on its own decreases. A swollen kidney in an otherwise healthy newborn is a waiting game; a swollen kidney in a newborn with a congenital anomaly or a urinary tract infection is a signal that the underlying anatomy or physiology may need active management.

For the clinical community, these correlations translate directly into follow-up strategy. The findings suggest that the routine postnatal workup, which often includes ultrasound surveillance and, in selected cases, a micturating cysto-urethrogram to exclude reflux, can be calibrated to the infant’s overall health status. Newborns free of comorbidities can be followed with confidence and minimal invasiveness, while those with congenital anomalies or early infections warrant tighter imaging intervals and a lower threshold for investigating obstruction or reflux. The study’s authors are careful to note that these associations are correlational, not causal, and that validation in future cohorts is essential before the numbers become firm clinical rules.

For parents, the reassurance value may be the study’s most viral contribution. Antenatal hydronephrosis generates enormous anxiety precisely because it is discovered before birth, when families have months to imagine the worst. The new data show that in more than nine out of ten cases, the condition melts away within the first year, and in almost all of those, within the first two months. The infant who needs surgery is the rare exception, not the rule, and the presence of other health problems, not the severity of the kidney swelling alone, is what tips the balance toward intervention.

The study is not without limitations, and the authors acknowledge them candidly. It is a single-centre retrospective review, which means referral patterns and local practice could shape the cohort in ways a multi-centre prospective design would control. The exclusion of infants lost to follow-up, while necessary for analytical integrity, removes exactly the cases whose outcomes might be least typical. And the definition of recovery as an APD of 10 millimetres or less, though widely used, is one threshold among several proposed in the literature. Still, the scale of the cohort, nearly two hundred infants tracked over five years, and the consistency of the comorbidity correlations give the findings real weight.

What the Randwick team has produced, in the end, is a natural history map of one of prenatal medicine’s most common findings. It tells clinicians where to look, at the infant with comorbidities rather than the infant with isolated swelling, and when to look, in the first two months rather than across an anxious year. It tells parents that the odds overwhelmingly favour spontaneous resolution. And it reminds the field that sometimes the most powerful diagnostic tool is time itself, allowed to run its course under careful observation.

Subject of Research: Pediatrics

Article Title: Antenatally diagnosed hydronephrosis and determinants of spontaneous resolution

Article References: Raaijmakers, A., Tapawan, S., & Bolisetty, S. (2026). Antenatally diagnosed hydronephrosis and determinants of spontaneous resolution. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07628-2

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07628-2

Keywords: antenatal hydronephrosis, pediatrics, prenatal ultrasound, kidney, neonatology, spontaneous resolution, comorbidities, urinary tract infection, Antenatally, diagnosed, hydronephrosis, determinants

The research, published in BMC Pediatrics, comes from a team at Shanghai Children’s Medical Center led by Xinyi Xu and colleagues, including corresponding author Tingliang Liu. The investigators combed through fifteen years of clinical records, spanning 2009 to 2024, at their tertiary children’s hospital in China. From that archive they identified 101 children diagnosed with tachycardia-induced cardiomyopathy, 58 of them boys. The median age at diagnosis was strikingly young: just 1.4 years, with the middle half of patients falling between roughly four months and seven years old. That age profile alone tells an important story, because it means the condition frequently strikes infants and toddlers, patients too young to describe palpitations or chest discomfort and whose symptoms are easily mistaken for ordinary childhood illness.

The central finding concerns the arrhythmias that set the disease in motion. Focal atrial tachycardia, an abnormal rhythm originating from a discrete spot in the heart’s upper chambers, accounted for 55.4 percent of cases, making it by far the most common culprit. Other rhythm disturbances in the pediatric TIC spectrum include atrial flutter, atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia, chaotic atrial tachycardia, junctional ectopic tachycardia, and ventricular tachycardia. Each of these rhythms forces the ventricles, the heart’s main pumping chambers, to beat far faster than they were designed to. When that pace persists, the heart muscle exhausts itself in a way that cardiologists compare to a sprinter forced to run a marathon: the chambers dilate, the pumping fraction measured by echocardiography falls, and the child can slide into heart failure.

What makes TIC clinically fascinating, and diagnostically treacherous, is that the muscle damage is potentially reversible. Unlike many cardiomyopathies, which reflect intrinsic disease of the heart muscle itself, TIC is a secondary phenomenon: remove or control the arrhythmia, and the pump often recovers. The Shanghai team’s data quantify just how often that recovery happens. At a median follow-up of 34 months, ranging from 14 to 67 months, the tachyarrhythmia driving the disease had resolved spontaneously in 46 of the 101 patients, or 45.5 percent. In other words, in nearly half the cohort, the abnormal rhythm simply stopped on its own over time, and with it the stimulus that had been wearing the heart down.

The study goes beyond describing outcomes by identifying which children recover fastest. Using statistical modeling, the researchers pinpointed three independent predictors of recovery of the left ventricular ejection fraction, the standard measure of pumping strength. The first was age at TIC onset: each additional year of age at diagnosis was associated with a hazard ratio of 0.912 for ejection fraction recovery, with a 95 percent confidence interval of 0.863 to 0.964 and a p-value of 0.001. In practical terms, older children recovered more slowly than infants. The second predictor was the nature of the rhythm itself: incessant tachycardia, meaning an arrhythmia present nearly continuously rather than in intermittent bursts, carried a hazard ratio of 0.480, indicating markedly slower recovery of pumping function. The third was the baseline degree of left ventricular dilation, measured as the end-diastolic dimension Z-score, a statistical correction that accounts for a child’s body size. For every one standard deviation increase in that Z-score, the hazard ratio for recovery was 0.828, meaning a more stretched-out ventricle at diagnosis predicted a slower climb back to normal function.

These predictors give clinicians a practical risk stratification tool. A toddler whose heart races around the clock and whose left ventricle is already significantly dilated at presentation is the patient who will need the most aggressive rhythm control and the closest monitoring. Conversely, an infant with a milder, intermittent arrhythmia and a ventricle that is only mildly enlarged has a good prognosis even before treatment begins. The findings also reinforce a principle that pediatric cardiologists have long suspected: the duration and burden of the tachycardia, not merely its type, determine how much the heart suffers and how long it takes to heal.

Infants, however, occupy a paradoxical position in the study’s results. On one hand, children aged one year or younger had dramatically better odds of spontaneous resolution of their arrhythmia, with an odds ratio of 8.309 compared with older children. The immature heart’s conduction system, for reasons the study does not fully resolve, appears more likely to simply outgrow certain abnormal rhythms. On the other hand, when infants did require catheter ablation, the procedure that threads catheters into the heart to destroy the tissue generating the abnormal rhythm, their complication rates were sobering. Ablation-related adverse events occurred in 66.7 percent of children one year old or younger, two out of three patients in that small subgroup, compared with just 8.7 percent of children older than one year, four out of 46. The difference was statistically significant, with a p-value of 0.04.

That trade-off sits at the heart of the clinical dilemma the study illuminates. Ablation in a tiny infant is technically demanding: the heart is the size of a walnut, the arrhythmia focus may be millimeters across, and the catheters and mapping systems were largely engineered for adult anatomy. Yet waiting for spontaneous resolution is not always safe when the heart is failing. The study’s numbers suggest a reasoned approach: in infants, particularly those whose arrhythmias are intermittent and whose ventricles are not severely dilated, a strategy of medical rhythm control and watchful waiting may be justified by the high likelihood of spontaneous resolution. In older children, where spontaneous resolution is less common and ablation is far safer, earlier catheter-based intervention becomes more attractive, especially when the arrhythmia is incessant and the clock is ticking on ventricular recovery.

The broader significance of the study lies in its scale and duration. Fifteen years of single-center experience with 101 patients is a substantial dataset for a condition that most pediatric centers encounter only a handful of times per decade. Because the analysis is retrospective, it inherits the limitations of that design: treatment decisions were made by individual clinicians rather than a protocol, and the findings describe associations rather than the effects of randomized interventions. Still, the consistency of the three prognostic factors, age, arrhythmia persistence, and ventricular dilation, across the statistical models gives the results weight, and the cohort size lends the estimates a precision that smaller case series cannot match.

For families, the headline message is ultimately an encouraging one. Most children in the study recovered fully once their heart rhythm was brought under control, whether through medication, ablation, or the arrhythmia’s own spontaneous disappearance. Tachycardia-induced cardiomyopathy, frightening as it sounds when a child’s ejection fraction plummets, is in most cases a temporary state rather than a permanent sentence. The challenge, as the Shanghai data make clear, is matching the right treatment to the right child at the right time: protecting the hearts of infants whose rhythms may resolve on their own, while moving decisively in older children whose incessant arrhythmias and dilated ventricles signal a longer, harder road to recovery. With this fifteen-year map in hand, pediatric cardiologists now have firmer ground on which to make those decisions.

Subject of Research: Clinical management and prognosis of tachycardia-induced cardiomyopathy in children

Article Title: Clinical management and prognosis of tachycardia-induced cardiomyopathy in children: a retrospective cohort study with 15-year single-center experience

Article References: Xu, X., Feng, W., Wang, K., Ji, W., Guo, Y., Wu, J., Chen, Y., Zhu, D., Li, F., & Liu, T. (2026). Clinical management and prognosis of tachycardia-induced cardiomyopathy in children: a retrospective cohort study with 15-year single-center experience. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07712-7

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07712-7

Keywords: tachycardia-induced cardiomyopathy, pediatric cardiology, arrhythmia, focal atrial tachycardia, catheter ablation, left ventricular ejection fraction, heart failure in children, spontaneous resolution, infants, retrospective cohort study, echocardiography, prognosis